Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
Status:
Completed
Trial end date:
2021-04-22
Target enrollment:
Participant gender:
Summary
This is a randomized, placebo-controlled, double-blind, 16 week trial of the medication
zonisamide for the treatment of heavy drinking alcoholic civilians.
Phase:
Phase 3
Details
Lead Sponsor:
Virginia Commonwealth University Yale University
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) University of Connecticut VA Connecticut Healthcare System Yale University